Myriad Genetics, Inc. (MYGN)

CTI BioPharma Market Cap

Myriad Genetics has a market cap or net worth of $360.41 million as of August 1, 2025. Its market cap has decreased by -85.46% in one year.

• Market Cap: 360.41M
• Enterprise Value: 426.21M
• 1-Year Change: -85.46%
• Ranking: #3221
• Category: Small-Cap
• Stock Price: $3.91

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $360.41M, an increase of 252.31%. That is a compound annual growth rate of 4.83%.

Market Cap History

Date	Market Cap	% Change
Jul 31, 2025	354.00M	-71.64%
Dec 31, 2024	1.25B	-20.67%
Dec 29, 2023	1.57B	33.81%
Dec 30, 2022	1.18B	-46.65%
Dec 31, 2021	2.20B	48.19%
Dec 31, 2020	1.49B	-26.57%
Dec 31, 2019	2.03B	-6.80%
Dec 31, 2018	2.17B	-8.61%
Dec 29, 2017	2.38B	108.51%
Dec 30, 2016	1.14B	-62.13%
Dec 31, 2015	3.01B	21.14%
Dec 31, 2014	2.49B	58.51%
Dec 31, 2013	1.57B	-29.30%
Dec 31, 2012	2.22B	25.03%
Dec 30, 2011	1.77B	-15.91%
Dec 31, 2010	2.11B	-15.93%
Dec 31, 2009	2.51B	-18.54%
Dec 31, 2008	3.08B	50.95%
Dec 31, 2007	2.04B	64.00%
Dec 29, 2006	1.24B	93.29%
Dec 30, 2005	643.90M	-6.71%
Dec 31, 2004	690.20M	98.11%
Dec 31, 2003	348.40M	-0.17%
Dec 31, 2002	349.00M	-71.84%
Dec 31, 2001	1.24B	-34.15%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	664.39B
Johnson & Johnson	396.75B
AbbVie	333.89B
AstraZeneca	232.21B
UnitedHealth Group	226.39B
Novartis AG	224.47B
Abbott Laboratories	219.63B
Novo Nordisk	213.92B